Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.
about
Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) StudyPrevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.Management of Resistant Hypertension: Do Not Give Up on Medication.Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.African Americans' Perceptions of Adherence to Medications and Lifestyle Changes Prescribed to Treat Hypertension.Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence.The influence of frailty syndrome on medication adherence among elderly patients with hypertension.Selected factors affecting adherence in the pharmacological treatment of arterial hypertension.Resistant hypertension: a practical clinical approach.Monitoring treatment adherence in hypertension.How will the growing threat of resistant hypertension impact the future treatment of high blood pressure?The ROX coupler: creation of a fixed iliac arteriovenous anastomosis for the treatment of uncontrolled systemic arterial hypertension, exploiting the physical properties of the arterial vasculature.Can drugs work in patients who do not take them? The problem of non-adherence in resistant hypertension.Systolic Blood Pressure and Biochemical Assessment of Adherence: A Cross-Sectional Analysis in the Emergency Department.Mortality Risk Associated With Resistant Hypertension Among Women: Analysis from Three Prospective Cohorts Encompassing the Spectrum of Women's Heart Disease.Influence of initial angiotensin receptor blockers on treatment persistence in uncomplicated hypertension: A nation-wide population-based study.Psychosocial correlates of apparent treatment-resistant hypertension in the Jackson Heart Study.Improvement in All-Cause Mortality With Blood Pressure Control in a Group of US Veterans With Drug-Resistant Hypertension.Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.Common mental disorders: socio-demographic and pharmacotherapy profile.Improving Medication Adherence in Coronary Heart Disease.The influence of illness acceptance on the adherence to pharmacological and non-pharmacological therapy in patients with hypertension.New Strategy to Control Blood Pressure: Interactive Mobile Phone Support.Adherence to pharmacological and non-pharmacological treatment of frail hypertensive patients.Association of functional and structural social support with medication adherence among individuals treated for coronary heart disease risk factors: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
P2860
Q27026525-EAC69698-4E92-453B-A4C0-1E2BB6F84DCDQ33789175-208C9AD1-6425-403F-9D48-5D3E92D4C2C0Q33995658-64666139-2622-4109-8011-5CCDFEA3A82DQ35026633-3846A4CF-EF59-43CF-8B4E-3F901D1E32FBQ35763418-7A01996A-4E39-4543-9632-913380CF6B0BQ36463881-AEC0592F-C30D-4493-A85F-9F0202662558Q36792041-E88C64A4-DD8C-48B7-9707-65880424092CQ36858259-F590C20B-F01F-4FDC-8223-75AA3E6CF39BQ37443892-86C1502C-C735-4682-80BC-41246223A40EQ37496481-36806207-CC31-4E81-B45F-59F8CBC07F24Q37682872-6536B791-DA57-4D72-A052-18FC46B4CE46Q38103398-A293F4A2-C95B-4A30-8186-BA4AAC534590Q38119410-D7A6CEFE-E335-4740-AB2B-2CAE6CB713BAQ38154609-C4DBFC00-B02D-4B7C-9F37-AE37BF018DB6Q38262779-3DC65B86-7DBF-47D1-8918-FD08FDC5DE14Q38545377-404130B4-2C58-4B6A-95A8-41C1A5561097Q38707976-3F58FC38-C736-470D-8C19-A799A6B1CFF7Q39736861-80EC4380-0849-4605-A41A-3E3F08FE5A87Q39877267-E9F0555F-E8F5-4B15-A223-DE9A5CC2C2F5Q40363740-F408022F-31F8-4E98-AF5C-4058E7EA5760Q40461830-47EEB3A6-EC87-4B77-8A8C-21A51FA4BDEAQ42373752-11A8BF5C-D7A1-4923-893F-67DD6DF511EDQ46815849-2775B8BB-CE1B-4CD9-BE96-EB5913AD361DQ47760902-0B552BDA-7F0F-413B-9C96-C7F7A5102057Q50547129-23031E33-13EF-4483-B13D-C338DB418012Q50925006-34EDAD7F-0EC4-4EE7-B7D6-E597F1A8AC48Q53409120-C9AED94B-2F6A-403A-8E37-7E14E971B141Q55501501-FE662853-C5F8-4F06-800F-A1DEEE4E0006
P2860
Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prevalence and correlates of l ...... atment-resistant hypertension.
@ast
Prevalence and correlates of l ...... atment-resistant hypertension.
@en
type
label
Prevalence and correlates of l ...... atment-resistant hypertension.
@ast
Prevalence and correlates of l ...... atment-resistant hypertension.
@en
prefLabel
Prevalence and correlates of l ...... atment-resistant hypertension.
@ast
Prevalence and correlates of l ...... atment-resistant hypertension.
@en
P2093
P2860
P1476
Prevalence and correlates of l ...... atment-resistant hypertension.
@en
P2093
Daichi Shimbo
Daniel T Lackland
David A Calhoun
Devin M Mann
Kristi Reynolds
Marie Krousel-Wood
Nita A Limdi
Paul Muntner
Suzanne Oparil
P2860
P304
P356
10.1111/J.1751-7176.2012.00690.X
P577
2012-08-03T00:00:00Z